NOKE LAB Expands Ultra-Clean Vial & Closure Manufacturing Capacity

NOKE LAB Expands Ultra-Clean Vial & Closure Manufacturing Capacity

Major investment will triple production capacity for chromatography consumables to meet growing global demand from pharmaceutical and research laboratories.

Expansion Overview

NOKE LAB announced a major expansion of its ultra-clean production capacity for chromatography consumables, including vials, caps, septa, syringe filters, and SPE products. The upgrade strengthens background control, batch traceability, and delivery reliability for global laboratories and distributors.

Investment Details

The $15 million investment includes new Class 100,000 cleanroom facilities, state-of-the-art injection molding equipment, and advanced AI vision inspection systems. These improvements will enable us to meet the growing demand from pharmaceutical, environmental, and research laboratories worldwide.

New Capabilities

Key improvements include:

  • Expanded precision assembly and inspection capacity with AI vision systems
  • Enhanced background control testing workflows for GC/MS applications
  • More configuration options for vials, caps, and septa
  • Bonded cap technology for adhesive-free sealing

Timeline

The expansion is scheduled for completion in Q3 2026, with phased rollout of new production lines beginning in Q2. Early access programs are available for key distribution partners.

About NOKE LAB

Founded in 2016, NOKE LAB is a leading manufacturer of chromatography consumables serving laboratories in 50+ countries. Our focus on ultra-clean production and consistent quality has made us a trusted partner for pharmaceutical companies, research institutions, and environmental testing laboratories worldwide.